Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review

被引:31
作者
Nandy, Nina [1 ]
Dasanu, Constantin A. [2 ]
机构
[1] Univ Connecticut, Hartford, CT 06103 USA
[2] Med Oncol & Blood Disorders, Hartford, CT USA
关键词
Chemoprevention; Esophageal cancer; Prognosis; Second primary malignancy; MULTIPLE PRIMARY CANCERS; SQUAMOUS-CELL CARCINOMA; BARRETTS-ESOPHAGUS; FIELD CANCERIZATION; COLORECTAL-CANCER; GASTRIC CARDIA; RISK-FACTORS; ASPIRIN; ADENOCARCINOMA; ASSOCIATION;
D O I
10.1185/03007995.2013.816276
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Development of a second primary malignancy (SPM) after an index esophageal cancer is fairly rare, primarily due to decreased survival in patients with esophageal cancer. However, with advances in early detection and therapy, the number of long-term survivors is increasing, as is the incidence of SPMs in this population. Scope: We review herein the published literature on the incidence of SPMs after an index esophageal cancer as well as its associated risk factors, prognosis and surveillance. We discuss predisposing factors that may contribute to the development of SPMs, epidemiology and attempts at chemoprevention. Findings: Data from population-based studies, retrospective reviews and case reports indicate an increased risk of SPMs in patients with esophageal cancer with reported incidence rates between 8.3 and 27.1%. Index esophageal squamous cell carcinomas have a higher association with other tobacco-related cancers such as those of the head and neck and lung. They have also shown an association with second primary cancers of the breast, stomach, thyroid, and kidney. Individuals with esophageal adenocarcinomas are at a higher risk of developing second cancers of the stomach, oropharynx and lung/bronchus. Other primary cancer sites involved include the kidney, colorectum and pancreas. Common risk factors including lifestyle and genetic alterations may explain the increased incidence of second primary cancers in this patient population. Conclusions: Risk of developing a second malignancy should be anticipated after curative treatment of esophageal cancer, and raises concerns for optimal surveillance and therapy of these patients. Recent literature suggests similar survival rates in esophageal cancer patients with and without SPMs. With the increasing incidence of SPMs in subjects with esophageal cancer, there may be benefit to close screening for and aggressive therapy of SPMs. However, further studies are needed to elucidate optimal management strategies.
引用
收藏
页码:1055 / 1065
页数:11
相关论文
共 67 条
[1]  
ABO S, 1980, JPN J GASTROENTEROL, V13, P377
[2]   AUTOPSY FINDINGS IN CARCINOMA OF THE ESOPHAGUS [J].
BOSCH, A ;
FRIAS, Z ;
CALDWELL, WL ;
JAESCHKE, WH .
ACTA RADIOLOGICA ONCOLOGY, 1979, 18 (02) :103-112
[3]   Inhibition of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus by dietary freeze-dried strawberries [J].
Carlton, PS ;
Kresty, LA ;
Siglin, JC ;
Morse, MA ;
Lu, J ;
Morgan, C ;
Stoner, GD .
CARCINOGENESIS, 2001, 22 (03) :441-446
[4]   The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis [J].
Castellsagué, X ;
Quintana, MJ ;
Martínez, MC ;
Nieto, A ;
Sánchez, MJ ;
Juan, A ;
Monner, A ;
Carrera, M ;
Agudo, A ;
Quer, M ;
Muñoz, N ;
Herrero, R ;
Franceschi, S ;
Bosch, FX .
INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (05) :741-749
[5]   Randomized Phase II Trial of Lyophilized Strawberries in Patients with Dysplastic Precancerous Lesions of the Esophagus [J].
Chen, Tong ;
Yan, Fei ;
Qian, Jiaming ;
Guo, Mingzhou ;
Zhang, Hongbing ;
Tang, Xiaofei ;
Chen, Fang ;
Stoner, Gary D. ;
Wang, Xiaomin .
CANCER PREVENTION RESEARCH, 2012, 5 (01) :41-50
[6]   Risk of second primary cancer among esophageal cancer patients: A pooled analysis of 13 cancer registries [J].
Chuang, Shu-Chun ;
Hashibe, Mia ;
Scelo, Ghislaine ;
Brewster, David H. ;
Pukkala, Eero ;
Friis, Soren ;
Tracey, Elizabeth ;
Weiderpass, Elisabete ;
Hemminki, Kari ;
Tamaro, Sharon ;
Chia, Kee-Seng ;
Pompe-Kim, Vera ;
Kliewer, Erich V. ;
Tonita, Jon M. ;
Martos, Carmen ;
Jonasson, Jon G. ;
Dresler, Carolyn M. ;
Boffetta, Paolo ;
Brennan, Paul .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (06) :1543-1549
[7]  
CHUNG KY, 1993, CANCER RES, V53, P1676
[8]   Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials [J].
Cole, Bernard F. ;
Logan, Richard F. ;
Halabi, Susan ;
Benamouzig, Robert ;
Sandler, Robert S. ;
Grainge, Matthew J. ;
Chaussade, Stanislas ;
Baron, John A. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (04) :256-266
[9]   Association of esophageal adenocarcinoma with other subsequent primary cancers [J].
Das, Ananya ;
Thomas, Sapna ;
Zablotska, Lydia B. ;
Neugut, Alfred I. ;
Chak, Amitabh .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (05) :405-411
[10]  
DeMeester SR, 2009, GASTROINTEST CANC RE, V3, pS1